Invite a friend to get their first reward.Claim 1000 Satoshis

I'm searching

For Hoomans

You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.

Rinvoq

Rinvoq (upadacitinib) is an oral Janus kinase (JAK) inhibitor used for the treatment of various inflammatory conditions, primarily moderate to severe rheumatoid arthritis (RA) in adults who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs). Rinvoq works by targeting specific pathways involved in the inflammatory process, helping to reduce symptoms and improve physical function.



Rx. Enter your prescription

How would you like to get your prescription? Select an option

Pharmacy pickup

Select from 35,000 pharmacies

Free two-day delivery

Coming soon!

Find a pharmacy near you. Enter your ZIP code

Please enter your ZIP to find pharmacies near you.

Are you a member? Sign up or log in.

Sign up for free to start earning Bitcoin rewards

Get your personal savings card. Watch your Bitcoin balance grow and get paid whenever you want.

Sign Up

Access my personal savings card

Get instant savings at my pick-up pharmacy and earn bitcoin in my NiHowdy account

Log In
backgroundbackground

Members have saved

$NaN

using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!

NaNM

worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.

How much Bitcoin can you earn with Rinvoq ?

The potential for Bitcoin rewards to increase and appreciate in value is a possibility to consider, which may occur over time.

See the value of your savings today

Today's Value

Bitcoin1 Bitcoin = $NaN

Bitcoin (BTC)

...

USD

$NaN

Adjust Bitcoin's potential value to see how much it could be worth

Potential Value

Bitcoin1 Bitcoin =

Bitcoin (BTC)

...

USD

$NaN

Frequently Asked Questions

How quickly does Rinvoq start to work?
Open FAQClose FAQ

Patients may start to notice improvements in symptoms within 1 to 2 weeks of starting treatment, but it may take longer for full effects to be realized.

Can I stop taking Rinvoq suddenly?
Open FAQClose FAQ

It is generally not advisable to stop Rinvoq abruptly without consulting your healthcare provider, as this may lead to a return of symptoms.

Can I stop taking Rinvoq suddenly?
Open FAQClose FAQ

It is generally not advisable to stop Rinvoq abruptly without consulting your healthcare provider, as this may lead to a return of symptoms.

Are there any specific dietary restrictions while taking Rinvoq?
Open FAQClose FAQ

There are no specific dietary restrictions, but maintaining a healthy lifestyle can support overall treatment effectiveness.

What should I do if I miss a dose of Rinvoq?
Open FAQClose FAQ

If you miss a dose, take it as soon as you remember on the same day. If it’s close to the time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.

Is Rinvoq safe for long-term use?
Open FAQClose FAQ

Rinvoq can be used long-term under medical supervision, but regular monitoring is essential to assess effectiveness and potential side effects, particularly concerning infections and liver function.

Comprehensive Drug Guide

How Does Rinvoq Work?

Rinvoq selectively inhibits JAK enzymes (JAK1 and JAK2), which play a crucial role in the signaling pathways of various cytokines involved in inflammation and immune responses. By inhibiting these pathways, Rinvoq reduces the production of inflammatory mediators, leading to decreased inflammation, pain, and improved function in patients with rheumatoid arthritis.



Common Dosages

  • Tablets: 15 mg and 30 mg

Typical Dosing

  • For rheumatoid arthritis: The recommended starting dose is 15 mg once daily. Based on the patient's response, the dose may be increased to 30 mg once daily

Typical Dosing

FDA Approved Indications

  • Treatment of moderate to severe rheumatoid arthritis in adults who have had an inadequate response to one or more DMARDs.
  • It is also indicated for other inflammatory conditions, including atopic dermatitis and ulcerative colitis, in specific patient populations.


Who Shouldn't Take Rinvoq?

  • Known hypersensitivity to upadacitinib or any of its components
  • Active infections, such as tuberculosis (TB) or severe bacterial infections
  • Severe hepatic impairment


Advice From The Pharmacist

  • Take Rinvoq exactly as prescribed, and do not exceed the recommended dose to minimize the risk of side effects.
  • Monitor for signs of infection, as JAK inhibitors can increase the risk of serious infections.
  • Regular follow-up appointments and laboratory tests may be necessary to monitor liver function and blood counts during treatment.


Side Effects of Rinvoq

Common Side Effects

  • Nausea
  • Headache
  • Increased liver enzymes
  • Upper respiratory infections


Uncommon/Severe Side Effects

  • Serious infections (such as tuberculosis or opportunistic infections)
  • Blood clots (thromboembolic events)
  • Gastrointestinal perforations


Risks and Warnings of Rinvoq

  • Infection Risk: Patients should be screened for latent TB before starting treatment, and ongoing monitoring for infections is essential.
  • Thromboembolic Events: There may be an increased risk of blood clots; patients should be educated on the signs and symptoms of deep vein thrombosis (DVT) and pulmonary embolism (PE).
  • Liver Function: Regular monitoring of liver enzymes is important, especially in the initial months of therapy.


Interactions with Rinvoq

Common Drug Interactions

  • Immunosuppressants: Caution is advised when used with other immunosuppressive agents, as this may increase the risk of infections.
  • CYP450 Enzyme Interactions: Upadacitinib is metabolized by CYP3A4; co-administration with strong inhibitors or inducers of this enzyme may require dose adjustments.


Alternatives to Rinvoq

  • Other JAK Inhibitors: Such as tofacitinib or baricitinib, which may be considered for similar indications.
  • Biologic DMARDs: Such as TNF inhibitors (e.g., adalimumab, etanercept) for managing rheumatoid arthritis.